Dinuclear platinum(II) complexes could offer a more targeted approach to treating prostate cancer Post author: Post published:December 16, 2024 Post category:uncategorized Prostate cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer among men. You Might Also Like Quantum simulation drives breakthrough in drug development July 31, 2024 Insilico Medicine’s AI-driven drug Rentosertib receives official generic name March 7, 2025 New AI tool identifies key human factors influencing maternity care outcomes November 20, 2024